Ethics and Cluster trials Dr Sarah JL Edwards Senior Lecturer, Research Ethics and Governance.

Slides:



Advertisements
Similar presentations
Research café: clinical education Dr Karen Mattick, Senior Lecturer, PCMD.
Advertisements

A feasibility study to explore patient, clinician and GP decision making of acute recurrent tonsillitis for NATTINA: The NAtional Trial of Tonsillectomy.
“Rational Pharmacology” and Health Economics By Alan Maynard.
Health service utilization by patients with common mental disorder identified by the Self Reporting Questionnaire in a primary care setting in Zomba, Malawi.
Addressing the Challenge of Neonatal Mortality
Recruitment to Trials. Background Recruitment of participants is a VERY important issue. The general consensus is that most trials under recuit.
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2013.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2009.
Clinical Trials Hanyan Yang
Making Cost Effectiveness Analyses more useful: Budget Impact Curves Christopher McCabe PhD Endowed Research Chair in Emergency Medicine Research University.
Basics: 2As & R Clinical Intervention Artwork by Nancy Z. © 2010 American Aca0emy of Pediatrics (AAP) Children's Art Contest. Support for the 2010 AAP.
Early Detection of breast cancer Anthony B. Miller, MD, FRCP Associate Director, Research, Dalla Lana School of Public Health, University of Toronto, Canada.
Introduction to evidence based medicine
CTU survey Dr Oluseun Adeogun NIHR Research Methods Fellow in Health Informatics University Of Liverpool / North West Hub for Trials Methodology Research.
International Forum - Quality & Safety in Healthcare |1 | An overview of the Guidance points Ethical issues in Patient Safety Research An overview.
Primary Care Research in Northern Ireland: where’s the evidence? Carmel M. Hughes School of Pharmacy Queen’s University Belfast.
Systematic reviews in the social sciences Sarah Whitehead, Cardiff Institute of Society and Health.
1 Lecture 20: Non-experimental studies of interventions Describe the levels of evaluation (structure, process, outcome) and give examples of measures of.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Discussion Gitanjali Batmanabane MD PhD. Do you look like this?
Mentoring for Excluded Groups and Networks (MEGAN) Peer Review Report Dr. Ioan Durnescu Brussels
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast Research methods: answering questions.
Smoking and Pregnancy: Status Profile 2007 Annie Berthiaume Roberta Heale Irene Koren Rachelle Arbour-Gagnon Funded by the Louise Picard Research Grant.
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
Wendy Preston Advanced Nurse Practitioner Ambulatory Care Lead Stop Smoking Manager BTS Stop Smoking Champion Senior Lecturer.
EVIDENCE BASED MEDICINE Effectiveness of therapy Ross Lawrenson.
Examination of the effects at one year of referral for brief intervention by an Alcohol Health Worker (AHW) on levels of alcohol consumption, psychiatric.
Intervention Studies - Cluster (Randomized) Trials Intervention at the cluster level - What are clusters? - Why intervene in clusters (rather than in individuals)?
Experimental studies Jean-François Boivin 25 October 2010.
E of computer-tailored S moking C essation A dvice in P rimary car E A Randomised Controlled Trial ffectiveness Hazel Gilbert Department of Primary Care.
Prevention of Alcohol Purchase and Use Among Adolescents Design Two: Staggered Entry of 10 Intervention Sites Harold D. Holder, Ph.D. Senior Scientist,
“Reaching across Arizona to provide comprehensive quality health care for those in need” AHCCCS/ADHS Report Summary & Recommendations.
What happens when the research is over? Researcher and funder perspectives J Whitworth Head of International Activities Wellcome Trust Global Forum on.
Community based integrated intervention for prevention and management of Chronic Obstructive Pulmonary Disease in Guangdong, China: cluster randomised.
Effect of community-wide isoniazid preventive therapy on tuberculosis among South African gold miners “Thibelo TB” Aurum Health Research LSHTM JHU Gold.
CEACEA CENTROCENTRO DE ESTUDIOS EN ADICCION Testing an Intervention Model to Reduce HIV/AIDS Among Hispanic Drug Users Residing in Puerto Rico Robles RR,
Department of International Health Chlorhexidine Umbilical Cord Antisepsis and Neonatal Outcomes: Current Evidence James Tielsch, Ph.D. Bangkok, March.
Smoking and Mental Health Problems in Treatment-Seeking University Students Eric Heiligenstein, M.D. University of Wisconsin-Madison Health Services Stevens.
Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.
1 Evaluation of Patient-Centered Medical Home (PCMH) Initiatives Meredith B. Rosenthal, PhD February 24, 2009.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
Compliance Original Study Design Randomised Surgical care Medical care.
1 Lecture 11: Cluster randomized and community trials Clusters, groups, communities Why allocate clusters vs individuals? Randomized vs nonrandomized designs.
Pilot and Feasibility Studies NIHR Research Design Service Sam Norton, Liz Steed, Lauren Bell.
Lipid Lowering Drug Prescribing: ‘patchy’ guideline adherence despite multi-faceted interventions M.E. Cupples 1, Terry Bradley, Chris Hall 1 Dept General.
Learning About Drug Use1 An Overview of the Process of Changing Drug Use 1. EXAMINE Measure Existing Practices (Descriptive Quantitative Studies) 2. DIAGNOSE.
THE EFFECTIVENESS OF PRE-TRAVEL HEALTH ADVICE IN COMMUNICABLE DISEASE MANAGEMENT SAMANTHA DEVLIN ( ) SOC30011: Social Research Design Assessment.
ZAMSTAR restricted randomisation CREATE Investigators Meeting 2005 Charalambos (Babis) Sismanidis LSHTM.
Why not teach mother? Maternal Education in Chlorhexidine Application to Prevent Omphalitis in Rural Kenya Zoë Clark, MS3 David Fischman, MS3 Anna Vestling,
Managed Care Models: The Benefit vs. Cost Balance
Study Designs Group Work
Participants 18year old+
Ruth Sepper Katrin Gross-Paju
No one gets left behind: Addressing the hidden burden of hepatitis C related advanced liver disease in PWID in the community John S Lambert, MD, PhD.
Health-care interactions and placebo effects:
Cluster Randomized Trials
Amanda Lilley-Kelly Senior Trial Co-ordinator
Personalized prevention: mobile application for smokers
Kandeke C, Chibuta C, Banda D
Key Question WHY USE A NON-TRADITIONAL RCT DESIGN?
Tim Auton, Astellas September 2014
Ethical issues in Community Trials
Cluster randomized trials
IMPACT OF PHARMACIST DELIVERED CARE IN THE COMMUNITY PHARMACY SETTING
Nadine Hendrie Dr Catherine Marchand Dr Grant McGeechan
Diabetes Self-Management Education and Support: Component of Standard Diabetes Care 1, 2 “… Ongoing patient self-management education and support are.
Ethics in cluster randomized trials
Surgical safety checklist trial
Presentation transcript:

Ethics and Cluster trials Dr Sarah JL Edwards Senior Lecturer, Research Ethics and Governance

Cluster randomized trials are increasingly being used in health and health services research Illustrate the types of CRTs; Identify some ethical issues in review Refer to literature and guidance Ethics and study design: Cluster randomized trials in health research

Cluster randomized trials Complex studies Units of randomization are clusters or groups Study intervention may be delivered to: the cluster as a unit (cluster-cluster trial) health professionals (professional-cluster trial) individual cluster members (individual-cluster trial) Outcomes are measured on individuals. Ethics and study design: Cluster randomized trials in health research

COMMIT trial (cluster-cluster trial) Unit of randomisation: US and Canadian Communities Intervention: Multimodal community-level intervention to reduce cigarette consumption including media and billboard campaign and targeted messaging toward smokers from health professionals Data collection: Interviews with a random sample of smokers in each community, the amounts of tobacco purchased by people living in the intervention and control communities. Result: Intervention led to an improved quit rate for mild to moderate smokers, with no effect on the quit rate of heavy smokers. Ethics and study design: Cluster randomized trials in health research

Improving primary care prescribing (professional-cluster trial) Unit of randomisation: General practitioners in Ireland Intervention: Personalized summary by mail of prescribing practices of antiplatelet and lipid lowering drugs plus an educational visit versus personalized summary of prescribing practices alone Data collection: Data on prescribing practices from the national pharmacy insurance program database. Data on prescribing practices were aggregated by physician and contained no identifiable information Result: Both interventions led to similar improvements. Ethics and study design: Cluster randomized trials in health research

Cleansing of the umbilical stump in neonates (individual-cluster trial) Unit of randomisation: Geographical areas in Nepal Intervention: Community health workers provide cleaning the umbilical stump with chlorhexidine versus soap and water versus dry stump care Data collection: Incidence of infection through clinical examination during household visits (15,000 infants), neonatal mortality, questionnaires about the household and infant care Result: Chlorhexidine reduced infection of the umbilical stump by 75% and neonatal mortality by 24%. Ethics and study design: Cluster randomized trials in health research

Rationale important: -Test how generalisable previous results have been -Test cluster level intervention -Avoid contamination between trial arms e.g. educational or behavioural interventions -Capture ‘herd’ or group effects e.g. vaccines -Speed up community roll out of experimental medicine

Right to health and prior evidence of efficacy might render cluster trial unjustified Treatment Action Campaign and Others v. Minister of Health and Others Constitutional Court of South Africa; 2002

1. In whose interests? Choice and size of cluster Moral status of social groups is not well understood Determine group interests: average, aggregate? Individual interests: each and every best interests? Ethics and study design: Cluster randomized trials in health research

2. Who is research subject? CRTs are complex and have multiple levels: e.g., hospitals are randomized, health care workers receive experimental intervention, and patient outcomes are assessed Complicates the identification of research participants From whom is informed consent required, if anyone? Ethics and study design: Cluster randomized trials in health research

3. Who represents group? In a CRT, clusters may be randomized prior to the identification of individual cluster members Is consent to randomization required? If so from whom ought it be sought? May gatekeepers provide consent to randomization? Person politically represent group anyway? What are his/her duties? Ethics and study design: Cluster randomized trials in health research

4. Consent to receive intervention In a CRT, the study intervention may be directed at the individual or the cluster or both Cluster level interventions (e.g., public educational messages or fluoridation of water supply) may be difficult for individual cluster members to avoid In such cases, refusal of study participation may be meaningless. Ethics and study design: Cluster randomized trials in health research

5. Consent to submit data on outcomes In a CRT, the outcomes relate to individuals within clusters Individuals may not have consented to randomisation of group or to receive experimental intervention especially if in control group Risk of contamination may be rationale for using cluster design. Ethics and study design: Cluster randomized trials in health research

MRC 2001 Ethical and methodological issues following BMJ paper 1999 by Edwards et al.

Ethics and study design: Cluster randomized trials in health research

Acknowledgements HTA for funding in 1999 Canadian NIH, Ottowa Statement MRC PhD candidate, Sapfo Lignou, for work on ideas of community Wellcome Trust PhD candidate, Elizabeth Oduwo, right to health UCL BRC funded work on use of cluster designs during pandemic WHO conference 6 th June 2014